Sunday, December 20, 2015

More Patients with Lung Cancer Could Benefit from Immunotherapy, Study Shows

…   More patients with advanced non-small-cell lung cancer (NSCLC) could benefit from pembrolizumab … line in patients with refractory lung cancer selected for PD-L1 expression. From …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)